IIM
CORZ icon

IFC & Insurance Marketing’s Core Scientific CORZ Stock Holding History

IFC & Insurance Marketing’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,132
Closed -$75K – 173
2025
Q4 		$75K Buy
+5,132
New +$89.5K 0.07% 134

Other funds holding CORZ

SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

IFC & Insurance Marketing's CORZ Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of Core Scientific (CORZ) in Q1 2026, closing a stake of 5,132 shares — an estimated $75K sold.

IFC & Insurance Marketing first reported a position in CORZ in Q4 2025 and held it in 1 quarter. The position peaked at $75K in Q4 2025. 387 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • IFC & Insurance Marketing reported no remaining Core Scientific position as of Q1 2026 after selling out during the quarter.
  • IFC & Insurance Marketing sold 5,132 Core Scientific shares in Q1 2026, an estimated $75K.
  • IFC & Insurance Marketing first reported a position in Core Scientific in Q4 2025 and held it in 1 quarter.
  • IFC & Insurance Marketing's Core Scientific position peaked at $75K in Q4 2025.
  • 387 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.